<DOC>
	<DOCNO>NCT01092455</DOCNO>
	<brief_summary>The purpose study determine whether use Citrasate® , citric acid dialysate enables reduction heparin N ( anticoagulant ) dose patient undergoing hemodialysis .</brief_summary>
	<brief_title>Multi-center Study Investigate Effects Citrasate® Heparin N Requirements During Hemodialysis Treatment</brief_title>
	<detailed_description>During hemodialysis , waste product remove blood diffusion across dialyzer membrane electrolyte solution know dialysate . Dialysate produce acid concentrate , bicarbonate solution water use three stream proportion system mixes acid concentrate , bicarbonate water produce final dialysate . Patients typically anticoagulated heparin dialysis prevent blood clot extracorpoeial circuit . Heparin use associate significant risk include possibility bleeding , heparin induce thrombocytopenia ( HIT ) contamination . For reason , possibility reduce heparin dose maintain HD adequacy clinically attractive . Citrasate® FDA approve acid concentrate contains citric acid ( citrate ) rather acetic acid ( acetate ) traditionally use acid concentrate . Citrate high concentration also know anticoagulant . We therefore conduct study determine whether use Citrasate , citric acid dialysate enables reduction heparin requirement patient undergoing hemodialysis .</detailed_description>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Subject capable give informed consent , acceptable surrogate capable give consent subject 's behalf . ESRD maintain thrice weekly HD Stable Heparin prescription ( Heparin dose ) previous 4 week Dialyzed use bolus heparin anticoagulation dose &gt; /= 2000 unit per treatment Hgb &gt; /= 9.5 prior study start eKt/V &gt; /= 1.0 ( spKt/V &gt; /= 1.2 ) monthly lab work prior study start Any laboratory abnormality , medical condition psychiatric disorder opinion investigator would put subject 's disease management risk may result subject unable comply study requirement Patient maintain Coumadin therapy LMW heparin Known history HIT , coagulopathy bleed and/or thrombotic disorder Patients dialyze &lt; 2000 unit Heparin per treatment Dialyzed without heparin Known pregnancy Dialyzed reuse hemodialyzer Documented clotted dialyzer dialysis line last 30 day ( 1 month ) require change dialyzer , bloodline terminate treatment Randomized clinical trial involve anticoagulation last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>End Stage Renal Disease</keyword>
	<keyword>Renal Dialysis</keyword>
	<keyword>Hemodialysis therapy</keyword>
	<keyword>Heparin</keyword>
	<keyword>Citrasate</keyword>
	<keyword>Anticoagulant</keyword>
</DOC>